Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Provectus Biopharmaceuticals logo — company profile

Provectus Biopharmaceuticals

Founded 2004 United States Knoxville, United States 8 employees

General Information

Company Name Provectus Biopharmaceuticals
Founded Year 2004
Location United States Knoxville, United States +1
Employees 8
Social

Get notified when Provectus Biopharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Provectus Biopharmaceuticals

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.

No funding data available for Provectus Biopharmaceuticals yet.

Get notified when Provectus Biopharmaceuticals raises funding

Provectus Biopharmaceuticals Alternatives & Competitors

Provectus Biopharmaceuticals vs
Provectus
Provectus United States

We help businesses leverage cloud, data, and AI to reimagine the way they operate, compete, and deli...

451 employees
AI, Entertainment
Provectus Biopharmaceuticals vs
Provectus CorpAdvisors
Provectus CorpAdvisors India

Your Trusted Remote Corporate Advisor!

22 employees
Financial Services
Provectus Biopharmaceuticals vs
Provectus Capital Partners
Provectus Capital Partners

Provectus Capital Partners (PCP) is a leading independent investment firm in South Eastern Europe (S...

12 employees
Financial Services

FAQ About Provectus Biopharmaceuticals

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.
Provectus Biopharmaceuticals was founded in 2004.
Provectus Biopharmaceuticals is headquartered in Knoxville, United States.
Provectus Biopharmaceuticals has approximately 8 employees.
Top alternatives and competitors to Provectus Biopharmaceuticals include Provectus, Provectus CorpAdvisors, Provectus Capital Partners, PROVECTUS PHARMACEUTICALS, University of Colorado Anschutz Cancer Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Provectus Biopharmaceuticals and Provectus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Provectus Biopharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes